SECsense Logo

BIO-key International, Inc. 8-K Filing: Key Insights from January 15, 2025

$BKYI
Form 8-K
Filed on: 2025-01-16
Source
BIO-key International, Inc. 8-K Filing: Key Insights from January 15, 2025

Based on the provided section of the financial report, here are the key extracted insights:

  1. Filing Type: The document is an 8-K filing, which is typically used to report major events that shareholders should know about.
  2. Company Information:
  • Company Name: BIO-key International, Inc.
  • State of Incorporation: Delaware (DE)
  • Company CIK: 0001019034
  • EIN: 41-1741861
  • Address: 101 Crawfords Corner Road, Suite 4116, Holmdel, NJ 07733
  • Phone Number: 732-359-1100
  1. Stock Information:
  • Common Stock Ticker: BKYI
  • Exchange: NASDAQ
  1. Reporting Period:
  • Start Date: January 15, 2025
  • End Date: January 15, 2025
  1. XML and XBRL Structure: The report is formatted in XBRL (eXtensible Business Reporting Language), which is commonly used for electronic filing of financial reports with the SEC.
  2. Schema Reference: The filing references a schema file named "bkyi-20250115.xsd", indicating the specific structure and definitions used for this report.

Overall, the document is an official SEC filing by BIO-key International, Inc. reporting a specific event on January 15, 2025. The information reflects the company's basic identification details, stock market presence, and the specific dates of the reporting period.